Rezension:
Good crew it\'s cool :) dilantin 300 mg While the exchanges aggressively battle over listings, it\'s largely a behind-the-scenes skirmish that doesn\'t matter much to investors anymore, Ritter says. \"Ten years ago, it would have made a difference,\" he says. \"But now, from an investor\'s point of view, it does not.\"
